[HTML][HTML] Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

…, MF Brady, WP McGuire, PG Harper… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
Purpose To determine if incorporation of an additional cytotoxic agent improves overall
survival (OS) and progression-free survival (PFS) for women with advanced-stage epithelial …

[PDF][PDF] Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer

…, D Smith, W Steward, PG Harper… - Journal of Clinical …, 2009 - researchgate.net
Purpose Both gemcitabine (GEM) and fluoropyrimidines are valuable treatment for advanced
pancreatic cancer. This open-label study was designed to compare the overall survival (OS…

Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter …

…, KM O'Donnell, NH Gower, PG Harper… - Journal of clinical …, 2006 - ascopubs.org
Purpose To replicate an earlier National Cancer Institute of Canada (NCIC) trial that examined
the effect on survival of the timing of thoracic radiotherapy (TRT) in patients with limited …

Challenges of change: a qualitative study of chronic care model implementation

…, LI Solberg, JAM Sperl-Hillen, PG Harper… - The Annals of Family …, 2006 - Annals Family Med
PURPOSE The Chronic Care Model (CCM) provides a conceptual framework for transforming
health care for patients with chronic conditions; however, little is known about how to best …

Five-day oral etoposide2 treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy

…, NH Gower, A Lamont, PG Harper - Journal of the …, 1997 - academic.oup.com
Background: Oral etoposide is an active single agent in small-cell lung cancer (SCLC) and
is widely prescribed as first-line treatment as an alternative to intravenous combination …

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial

T Eisen, H Joensuu, PD Nathan, PG Harper… - The lancet …, 2012 - thelancet.com
Background Regorafenib inhibits VEGF receptors 1, 2, and 3 and PDGF receptors like other
anti-angiogenic tyrosine-kinase inhibitors approved for treatment of advanced renal-cell …

Predictive and prognostic factors in small cell lung cancer: current status

D Yip, PG Harper - Lung cancer, 2000 - Elsevier
Clinical and laboratory parameters can predict response to chemotherapy and long term
survival in small cell lung cancer, and may predict those at risk of early treatment related toxicity…

Coexistence of acanthosis nigricans and the sign of Leser-Trelat in a patient with gastric adenocarcinoma: a case report and literature review

JSM Yeh, SE Munn, TA Plunkett, PG Harper… - Journal of the American …, 2000 - Elsevier
The association of acanthosis nigricans (AN) with the sign of Leser-Trélat (LT) and gastric
carcinoma is rare. Our patient was a 69-year-old man, who presented with hematemesis; a …

The nitrogen mustards

MS Highley, B Landuyt, H Prenen, PG Harper… - Pharmacological …, 2022 - ASPET
The nitrogen mustards are powerful cytotoxic and lymphoablative agents and have been
used for more than 60 years. They are employed in the treatment of cancers, sarcomas, and …

[PDF][PDF] Too many shots? Parent, nurse, and physician attitudes toward multiple simultaneous childhood vaccinations

DJ Madlon-Kay, PG Harper - Archives of Family Medicine, 1994 - triggered.clockss.org
Objective: To learn about parent, nurse, and family phy-sician attitudes toward multiple
simultaneous childhood vaccinations. Design: Survey. Setting: Thirty-two family practice clinics in …